Metabolic
Compounds studied for metabolism, glucose, and fat regulation.
Overview
Metabolic peptide research investigates regulators of glucose disposal, fatty-acid oxidation, hepatic lipid handling, and adipose-tissue endocrine signaling. The category spans approved incretin therapeutics (semaglutide, tirzepatide), GHRH analogs that modulate visceral adipose tissue (tesamorelin), and mitochondrial-derived peptides (MOTS-c, SS-31) that influence systemic insulin sensitivity from the cellular energetics layer. AMPK activators such as AICAR and 5-Amino-1MQ (an NNMT inhibitor) are studied for their effects on energy substrate switching and adipocyte methylation balance. Across the field, the dominant therapeutic question is whether sustained metabolic improvement can be achieved without indefinite pharmacology -- and which peptides modulate underlying biology versus only suppress appetite.
Biological Pathways
5-Amino-1MQ
Popular Name: 5-Amino-1-methylquinolinium, 5A1MQ, 5-amino-1-methylquinolinium salt
$XX.XX
AICAR
Popular Name: Acadesine, AICA-riboside, 5-aminoimidazole-4-carboxamide ribonucleotide
$XX.XX
AOD9604
Popular Name: AOD 9604, AOD-9604, Tyr-hGH 177-191
$XX.XX
Cagrilintide
Popular Name: AM833, Cagrilintide AM833, Long-acting amylin analog
$XX.XX
CJC-1295 With DAC
Popular Name: CJC-1295 DAC, CJC 1295 with DAC, CJC1295 DAC
$XX.XX
CJC-1295 Without DAC
Popular Name: CJC-1295 no DAC, Mod GRF 1-29, Modified GRF 1-29
$XX.XX